Release of platelet activating factor (PAF) and eicosanoids in UVC-irradiated corneal stromal cells
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Current Eye Research
- Vol. 14 (5) , 341-347
- https://doi.org/10.3109/02713689508999931
Abstract
Ultraviolet (UV) irradiation provokes acute inflammation of the eye, and can be used to model processes that occur in response to damage to the anterior segment. This study characterized ultraviolet-C (UVC, 254 nm) irradiation-induced PAF synthesis, and arachidonic acid (20:4) and eicosanoid release in rabbit comeal stromal cells maintained in vitro. PAF was measured by radioimmunoassay (RIA) after exposing cultured corneal stromal cells to UVC irradiation (20 min, 2, 5, 10 mW/cm2). 14C-20:4-labeled stromal cells were also stimulated with UVC and radiolabeled phospholipids, neutral lipids and eicosanoids were measured. Synthesis of cell-associated and secreted PAF from corneal stromal cells was increased by UV irradiation. UV irradiation (254 nm, 5mW/cm2) enhanced 20:4 release from triacylglycerols, phosphatidy-linositol, phosphatidylserine and phosphatidylethanolamine, and increased levels of 20:4-diacylglycerol and unesterified 20:4. The released 20:4 entered both the cyclooxygenase and lipoxygenase pathways after UVC irradiation. The PAF antagonist, BN52021 (10 μM) reduced UVC irradiation-induced stimulation of prostaglandin production, but failed to inhibit UVC-induced 20:4 release and synthesis of lipoxygenase products. Furthermore, exogenous PAF (1 μM) stimulated prostaglandin production, but did not increase the synthesis of lipoxygenase products from radiolabeled 20:4. The effects of PAF on prostaglandin synthesis were inhibited by BN52021. These findings indicate that responses to injury in cultured corneal stromal cells include PAF synthesis, release of 20:4 from glycerolipids, accumulation of diacylglycerol and synthesis of eicosanoids. The data further suggest that during UVC irradiation in vitro, PAF is not a primary or initial mediator of 20:4 release and synthesis of lipoxygenase products, but may mediate UVC-induced prostaglandin synthesis.Keywords
This publication has 20 references indexed in Scilit:
- The platelet-activating factor precursor of the injured cornea is selectively implicated in arachidonate and eicosanoid releaseCurrent Eye Research, 1993
- Intracamerally Injected Platelet Activating Factor (Paf) Induces Marked Intraocular Inflammatory ReactionsCurrent Eye Research, 1992
- Determination of MK-287, a new platelet-activating factor antagonist, in plasma and serum by gas chromatography chemical ionization mass spectrometryJournal of Mass Spectrometry, 1991
- Production of platelet-activating factor in photocoagulated retinasCurrent Eye Research, 1991
- Effects of ultraviolet irradiation on prostaglandin-E2 production by cultured corneal stromal cellsExperimental Eye Research, 1990
- The release of a neutrophil chemotactic factor from UV-B irradiated rabbit corneasin vitroCurrent Eye Research, 1990
- Platelet-Activating Factor Antagonist BN52021 Decreases Accumulation of Free Polyunsaturated Fatty Acid in Mouse Brain During Ischemia and Electroconvulsive ShockJournal of Neurochemistry, 1988
- The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase productsBiochemical and Biophysical Research Communications, 1987
- Inhibition of the Alkali Burn-Induced Lipoxygenation of Arachidonic Acid in the Rabbit CorneaIn Vivoby a Platelet Activating Factor AntagonistJournal of Ocular Pharmacology and Therapeutics, 1987
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959